Alasvand et al. (79) used this antagonist to intervene in tumor tissue and found that capillary density and VEGF level in tumor tissue decreased, confirming that NPY could regulate angiogenesis by activating the Y2 receptor on endothelial cells, but the specific mechanism was not precise. Here, NPY is linked to neoplasm.